Number of the records: 1  

Selective inhibition of cyclooxygenase-2 and activation of adenosine membrane receptors - two new promising approaches for treatment of radiation-induced myelosuppression

  1. 1.
    SYSNO ASEP0086704
    Document TypeA - Abstract
    R&D Document TypeThe record was not marked in the RIV
    R&D Document TypeNení vybrán druh dokumentu
    TitleSelective inhibition of cyclooxygenase-2 and activation of adenosine membrane receptors - two new promising approaches for treatment of radiation-induced myelosuppression
    TitleSelektivní inhibice cyklooxygenázy-2 a aktivace adenosinových receptorů - dva nové slibné přístupy k léčení zářením indukovaného poškození kostní dřeně
    Author(s) Hofer, Michal (BFU-R) RID, ORCID
    Pospíšil, Milan (BFU-R)
    Vacek, Antonín (BFU-R)
    Holá, Jiřina (BFU-R)
    Štreitová, Denisa (BFU-R)
    Znojil, V. (CZ)
    Source TitleAbstract Book. - San Francisco, 2007
    S. 123
    Number of pages1 s.
    Action13th International Congress of Radiation Research
    Event date08.07.2007-12.07.2007
    VEvent locationSan Francisco
    CountryUS - United States
    Event typeWRD
    Languageeng - English
    CountryUS - United States
    Keywordsradiation-induced myelosuppression ; cyclooxygenase-2 inhibition ; adenosine receptor activation
    Subject RIVBO - Biophysics
    R&D ProjectsGA305/06/0015 GA ČR - Czech Science Foundation (CSF)
    1QS500040507 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    CEZAV0Z50040507 - BFU-R (2005-2011)
    AV0Z50040702 - BFU-R (2007-2013)
    AnnotationIn this conference communication, a comprehensive information was given concerning experimental pharmacological treatment of radiation-suppressed hematopoiesis by inhibition of cyclooxygenase-2 and activation of adenosine receptors.
    WorkplaceInstitute of Biophysics
    ContactJana Poláková, polakova@ibp.cz, Tel.: 541 517 244
    Year of Publishing2008
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.